Effect of anti-VEGF treatment on choroidal thickness over time in patients with neovascular age-related macular degeneration.

@article{McDonnell2014EffectOA,
  title={Effect of anti-VEGF treatment on choroidal thickness over time in patients with neovascular age-related macular degeneration.},
  author={Emma C McDonnell and Florian M Heussen and Humberto Ruiz-Garcia and Yanling Ouyang and Ramsudha Narala and Alexander C. Walsh and Srinivas R. Sadda},
  journal={European journal of ophthalmology},
  year={2014},
  volume={24 6},
  pages={897-903}
}
PURPOSE To evaluate change in subfoveal choroidal thickness (SCT) as measured by spectral-domain optical coherence tomography (SD-OCT) in patients with neovascular age-related macular degeneration (NVAMD) undergoing anti-vascular endothelial growth factor (VEGF) therapy. METHODS Patients with a diagnosis of NVAMD were retrospectively reviewed to identify those who had at least 12 months of follow-up. The SCT was manually measured from Bruch membrane to the choroid-sclera junction at baseline… CONTINUE READING